Member Info for Forensic505

JammyC only ever comes on here to make negative comments. He seems to be a hired troll and a total kiss-ass on other boards eg RBGP. He needs to find more constructive ways to spend his twilight years.

youonly: completely agree ! I would add that they seem to have a habit of making up very cool but complex and confusing sounding names for fundamentally simple financial terms - it would be MUCH better making them simpler. Eg Instead of: "Entities with Contractual Liabilities (subject to theoretical appeal) to the Subject Entity"......just say: "Debtors" :-)

Feels like we're going into a penalty shoot-out :-)

Starting to look like the good old crazy days might be back !! :-)

at 1260p - this looks like a good buying opportunity DYOR of course

Good spot - thank you

The better the vaccine news, the better for Dunelm.

Good recovery this PM !! Phew - was a bit worried this morning....

After yesterday’s terrific performance will be interesting to see if momentum can be consolidated. GLA

Wow - what a great day !

TR1 just released. Mithaq Capital have increased from 16.1% to 17.4%

DaddyAIM: very good point about forthcoming treatment of Capital Gains !! Sunak seems to be flagging quite a hike to even income tax levels. Yikes !!! Hope not....doesnt seem very "Tory"...?

I agree. Very different models. BUR is big ticket funding of general litigation. High cost ticket and relatively longer duration. Increasing focus on the USA. MANO complete focus on buying (important difference) UK insolvency claims. BUR did have a dabble in the MANO pond many years ago (2014 ?) with a product called Sprint but this seems to have been quickly withdrawn. Not surprised - chalk and cheese from i can see. Both very good at what they do.

Agree with the comments here - very good results. Reassuring and impressive given the horrendous operating environment!

If you look at tax due on the IPO sell down and this sale, the net receivable here equates closely to the personal tax payable. Founders selling never easy optically but the figures do seem to work. If a founder sells at a high point that does seem to create a ceiling from what I can see that can sometimes cause real havoc to a sp. Selling at the bottom avoids that. Has no impact on the business of course.

Bigsmoke: glad someone has engaged some quality brainpower here...(to be fair there have been a few others who posted very high class analysis after the so called “Profit Warning”....but there was so much more to that RNS if people had bothered to read beyond the headline and teeth gnashing...)

But the vast majority in the echo chamber cannot see what is being delivered on a silver platter here....just unreal the childlike, sheeplike level of reaction. The quality of disclosure here has been world class. This is a gift. G....I......F......T. Wake up !

One point hopefully spells it out clearly: opportunity to buy at pretty much the IPO price a business that is 4x bigger than at the time of IPO. I usually sign off GLA. No luck required.

CVB: fully agree the openness and clarity of CEO and CFO was again very welcome. Not the first time I have said that re RBGP. I think we are all grown up enough to appreciate running any business is very difficult in these extraordinary times. So honesty is very welcome. GL.

Hi Scooby,

I agree. I think Convex will come back. Smart cost management in the short term but just a matter of time before it comes back. Just heard the presentation. Looks like Litigation Funding now aimed at smaller end of the Commercial Litigation market. So not competing with BUR on the mega cases, more against firms like Augusta on the smaller/medium end (think she said £3-5m++). So a pure funding (rather than acquisition) of cases. Insolvency no longer the focus (one case against MANO 90 cases I think they said). All sensible my only concern is cash resources - you need deep pockets because these cases take time of course. But i like a lot the idea of bringing in their High Net Worths to co-invest. Law firm seems to be going great and adding lateral hires in growth areas is spot on. SP has done v well recently but value looks reasonable as i think i'm right in saying it is still below IPO price (?) Much to like but dyor of course.

This company looks well poised to benefit from an early exit from restrictions. Lots of competition will have disappeared. Sold up various positions to take big bet here. GLA !

Cash balance needs to catch up with market cap before vaccine become ubiquitous....